4//SEC Filing
Thompson Tommy G 4
Accession 0001562180-25-002735
CIK 0001082554other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 4:31 PM ET
Size
10.5 KB
Accession
0001562180-25-002735
Insider Transaction Report
Form 4
Thompson Tommy G
Director
Transactions
- Exercise/Conversion
Common Stock
2025-03-24$175.43/sh+2,500$438,575→ 10,980 total - Sale
Common Stock
2025-03-24$318.80/sh−2,500$796,991→ 8,480 total - Exercise/Conversion
Stock Option
2025-03-24−2,500→ 2,500 totalExercise: $175.43From: 2016-06-26Exp: 2025-06-26→ Common Stock (2,500 underlying)
Holdings
- 8,200(indirect: By Trust)
Common Stock
- 5,800(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]Includes 880 shares of common stock to be issued on or about July 8, 2026, as the result of the July 7, 2023 vesting of RSUs for which the reporting person elected to defer receipt of shares.
- [F2]This transaction was executed in multiple trades at prices ranging from $318.43 to $319.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
UNITED THERAPEUTICS Corp
CIK 0001082554
Entity typeother
Related Parties
1- filerCIK 0001324863
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 4:31 PM ET
- Size
- 10.5 KB